Hakki Gursoz
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Off-label uses of Aflibercept, Ranibizumab and Dexamethasone implant for diabetic retinopathy in Turkey.
Journal: Romanian journal of ophthalmology
Published: December 03, 2022
Off-Label Uses of Ranibizumab and Aflibercept for Age-Related Macular Degeneration in Turkey.
Journal: Journal of current ophthalmology
Published: November 18, 2022
Evaluation of off-label anti-vascular endothelial growth factor and steroid implant medication uses in macular edema due to retinal vein occlusion in Turkey.
Journal: Journal of clinical pharmacy and therapeutics
Published: May 22, 2022
Evaluation of more than one billion outpatient prescriptions and eight-year trend showing a remarkable reduction in antibiotic prescription in Turkey: A success model of governmental interventions at national level.
Journal: Pharmacoepidemiology and drug safety
Published: March 19, 2021
Biological therapy for ocular Behçet's disease with off-label drug prescription in Turkey.
Journal: European journal of hospital pharmacy : science and practice
Published: March 07, 2021
Evaluation of the Performance of the Turkish Regulatory Agency: Recommendations for Improved Patients' Access to Medicines.
Journal: Frontiers in pharmacology
Published: September 27, 2019
Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study.
Journal: Journal of clinical pharmacy and therapeutics
Published: December 10, 2018
The Turkish Medicines and Medical Devices Agency: Comparison of Its Registration Process with Australia, Canada, Saudi Arabia, and Singapore.
Journal: Frontiers in pharmacology
Published: November 14, 2017
Impact of Health Policy Changes on Trends of Pharmaceutical Market in Turkey.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Impact Of Health Policy Changes on Unit Sales of 5 Top Selling Atc1 Phramaceutical Groups In Turkey.
Impact Of Health Policy Changes on Unit Sales of 5 Top Selling Atc1 Phramaceutical Groups In Turkey.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets In Turkey.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets of Top Selling Atc1 Phramaceutical Group (Alimentary and Metabolism (A0) In Turkey.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Last Updated: 09/26/2026